This page is dedicated to the Bronchiectasis research study, one of 57 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
The Bronchiectasis research study, established at Boston Children’s in 2019, is led by Drs. Benjamin Raby, Ruobing Wang, and Umakanth Katwa and has enrolled 145 patients and their families. The study aims to identify genetic causes of bronchiectasis and provide personalized medicine.